The Interventional Oncology Center

Filter Your Results




FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

Locoregional Therapy for Liver Metastases From Breast Cancer

Sarah B. White, MD, MS, FSIR; and Robert J. Lewandowski, MD, FSIR

January 2018—Current intra-arterial treatment options for women with hepatic-dominant breast cancer metastases.

Northwestern 15-Year Experience Informs Institutional Decision to Adopt Y-90 TARE as Primary Treatment for HCC

December 26, 2017 -- Findings from a study of yttrium-90 (Y-90) transarterial radioembolization (TARE) were published by Riad Salem, MD, et al online ahead of print in Hepato…

Y-90 Radioembolization Studied for Locally Advanced HCC With Portal Vein Thrombosis

December 21, 2017 -- Online in Journal of Nuclear Medicine, Nadine Abouchaleh et al reported survival outcomes for advanced stage hepatocellular carcinoma (HCC) with port…

Merit Medical to Acquire Needle Biopsy Products in Purchase Agreement With BD

November 21, 2017 -- Merit Medical Systems, Inc. announced that it has signed an asset purchase agreement to acquire with BD’s (Becton, Dickinson and Company) soft tissu…

Interventional Oncology: Precision in Practice

Ripal Gandhi, MD, FSVM; and David M. Liu, MD, FRCPC, FSIR

October 2017— Over the past decade, interventional oncology (IO) has seen a continued rise in enthusiasm from its practitioners. A mix of practica

The Interventional Oncology Clinic: Introduction to the IO Clinical Care Model

Eric A. Wang, MD; Mendi D. Mullis, MBA; and Megan E. Kanable, MHA

October 2017—Assessing interventional oncology patients in an outpatient clinic setting is essential for providing longitudinal and optimal care.

Five Must-Read Interventional Oncology Publications From the Last Year

Suvranu “Shoey” Ganguli, MD, FSIR

October 2017—Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma Salem R, Gordon AC, Mouli S, et a…



2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.